Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
11348 | 921 | 20.0 | 59% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
434 | 15650 | CHEMOTHERAPY-TOKYO//JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY//CEFEPIME |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CEFTIBUTEN | Author keyword | 10 | 35% | 3% | 24 |
2 | CEFDINIR | Author keyword | 8 | 28% | 2% | 23 |
3 | CEFETAMET PIVOXIL | Author keyword | 8 | 62% | 1% | 8 |
4 | CEFUROXIME AXETIL | Author keyword | 6 | 22% | 3% | 26 |
5 | CEFACLOR | Author keyword | 6 | 19% | 3% | 27 |
6 | ORAL CEPHALOSPORINS | Author keyword | 6 | 50% | 1% | 8 |
7 | CEFOTIAM HEXETIL | Author keyword | 4 | 67% | 0% | 4 |
8 | LORACARBEF | Author keyword | 4 | 33% | 1% | 9 |
9 | ORAL CEPHALOSPORIN | Author keyword | 3 | 32% | 1% | 7 |
10 | CEFETAMET | Author keyword | 3 | 35% | 1% | 6 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CEFTIBUTEN | 10 | 35% | 3% | 24 | Search CEFTIBUTEN | Search CEFTIBUTEN |
2 | CEFDINIR | 8 | 28% | 2% | 23 | Search CEFDINIR | Search CEFDINIR |
3 | CEFETAMET PIVOXIL | 8 | 62% | 1% | 8 | Search CEFETAMET+PIVOXIL | Search CEFETAMET+PIVOXIL |
4 | CEFUROXIME AXETIL | 6 | 22% | 3% | 26 | Search CEFUROXIME+AXETIL | Search CEFUROXIME+AXETIL |
5 | CEFACLOR | 6 | 19% | 3% | 27 | Search CEFACLOR | Search CEFACLOR |
6 | ORAL CEPHALOSPORINS | 6 | 50% | 1% | 8 | Search ORAL+CEPHALOSPORINS | Search ORAL+CEPHALOSPORINS |
7 | CEFOTIAM HEXETIL | 4 | 67% | 0% | 4 | Search CEFOTIAM+HEXETIL | Search CEFOTIAM+HEXETIL |
8 | LORACARBEF | 4 | 33% | 1% | 9 | Search LORACARBEF | Search LORACARBEF |
9 | ORAL CEPHALOSPORIN | 3 | 32% | 1% | 7 | Search ORAL+CEPHALOSPORIN | Search ORAL+CEPHALOSPORIN |
10 | CEFETAMET | 3 | 35% | 1% | 6 | Search CEFETAMET | Search CEFETAMET |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FK482 | 51 | 83% | 3% | 29 |
2 | ORAL CEPHALOSPORIN | 45 | 55% | 6% | 56 |
3 | SCH 39720 | 31 | 92% | 1% | 12 |
4 | U 76 252 CS 807 | 29 | 75% | 2% | 21 |
5 | BMY 28100 | 24 | 68% | 2% | 21 |
6 | 7432 S | 21 | 75% | 2% | 15 |
7 | LY163892 | 20 | 66% | 2% | 19 |
8 | ORAL CEPHALOSPORIN BMY 28100 | 20 | 100% | 1% | 9 |
9 | R 3746 | 19 | 70% | 2% | 16 |
10 | CEFACLOR | 17 | 27% | 6% | 53 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CEFTIBUTEN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND CLINICAL EFFICACY | 1994 | 25 | 44 | 73% |
Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate | 2007 | 13 | 25 | 64% |
CLINICAL PHARMACOKINETICS OF NEWER CEPHALOSPORINS | 1995 | 34 | 102 | 57% |
CEFPODOXIME PROXETIL - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL | 1992 | 29 | 54 | 76% |
Cefuroxime axetil - A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy | 1996 | 31 | 118 | 51% |
CEFIXIME - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL | 1989 | 41 | 40 | 83% |
Ceftibuten: An overview | 1997 | 9 | 48 | 77% |
CEFETAMET PIVOXIL - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE | 1993 | 17 | 87 | 69% |
Cefdinir - A review of its use in the management of mild-to-moderate bacterial infections | 2004 | 19 | 99 | 30% |
Cefuroxime Axetil - An updated review of its use in the management of bacterial infections | 2001 | 24 | 148 | 25% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MAJEEDIA HOSP | 1 | 27% | 0.3% | 3 |
2 | BIOASSAY SECT | 1 | 50% | 0.1% | 1 |
3 | PARTNERING CARE SENIOR SERV | 1 | 50% | 0.1% | 1 |
4 | NAT SCI ENGN INFORMAT | 0 | 25% | 0.1% | 1 |
5 | ASSOC RECH THER EUT | 0 | 20% | 0.1% | 1 |
6 | JMI | 0 | 20% | 0.1% | 1 |
7 | KLINIKUM ALBERT LUDWIGS | 0 | 20% | 0.1% | 1 |
8 | MICROBIOL CLIN MALAD INFECT | 0 | 20% | 0.1% | 1 |
9 | GERIATR PHARMACOTHER Y | 0 | 17% | 0.1% | 1 |
10 | UPJOHN 4302A | 0 | 17% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000133837 | CHEMOTHERAPY-TOKYO//BACTERIOLOGICAL RESPONSE//SULPHIMIDAZOLE |
2 | 0.0000115874 | AS 924//ORAL CEPHALOSPORIN//CEFCAPENE PIVOXIL |
3 | 0.0000113856 | PRULIFLOXACIN//ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS//ACUTE EXACERBATION OF CHRONIC BRONCHITIS |
4 | 0.0000086315 | PENICILLINS//CEPHALOSPORINS//AMOXICILLIN |
5 | 0.0000083832 | PHARYNGITIS//STREPTOCOCCAL PHARYNGITIS//THROAT CULTURE |
6 | 0.0000080829 | RUMINANT DIS EPIDEMIOL//SUCTION BLISTER METHOD//SKIN BLISTER FLUID CONCENTRATION |
7 | 0.0000079234 | BUNDESSTAATL BAKTERIOL SEROL UNTERSUCHUNGSANSTALT//KINDERHEILKUNDE KLIN PEDIATINFEKT ABT//ANTIMICROBIAL INTERACTION |
8 | 0.0000071397 | ACUTE OTITIS MEDIA//OTITIS MEDIA//OTITIS MEDIA WITH EFFUSION |
9 | 0.0000069609 | CEFQUINOME//PORPHYROMONAS LEVII//BOVINE NECROTIC VULVOVAGINITIS |
10 | 0.0000066937 | AMOXICILLIN SULBACTAM//SULTAMICILLIN//SULBACTAM |